By applying a robust analytical pipeline including eQTL mapping, MR, SMR, and mediation models, our findings not only enhance the understanding of AP pathophysiology, but also highlight YTHDF3 as a promising biomarker and potential target for future immune-based interventions. The gene discussed is YTHDF3; the disease is alkaline phosphatase measurement.